Economic evaluation of the routine use of echocardiography versus natriuretic peptide and ECG-targeted echocardiography in the diagnosis of heart failure

Book English OPEN
Stevenson, M.; Roberts, J.; Cowie, M.R.;

Objectives: To investigate the most efficient use of echocardiography and natriuretic peptide testing in the diagnosis of heart failure.\ud \ud Design: An economic model comparing two strategies: (A) provide echocardiography and electrocardiogram (ECG) for all individua... View more
  • References (16)
    16 references, page 1 of 2

    1 Peterson S, Rayner M, and Wolstenholme J. Coronary heart disease statistics: heart failure supplement. 2002. British Heart Foundation.

    2 Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC et al. The epidemiology of heart failure. Eur Heart J 1997;18:208-25.

    3 Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. E ur J Heart Fail 2002;4:361-71.

    4 National Collaborating Centre for Chronic Conditions. Chronic Heart Failure: National Clinical guideline for diagnosis and management in primary and secondary care. NICE Guideline No 5 (Full Version) 2003 Royal College of Physicians

    5 Leidy NK, Rentz AM, Zyczynski TM. Evaluating Health-Related Quality-of-Life Outcomes in Patients with Congestive Heart Failure: A Reviewof Recent Randomized Controlled Trials. Pharmacoeconomics 1999;15:19- 46.

    6 Davies LC, Francis DP, Piepoli M, Scott AC, Ponikowski P, Coats AJ. Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart 2000;83:147-51.

    7 Houghton AR, Sparrow NJ, Toms E, Cowley AJ. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? International Journal of Cardiology 1997;62:31-6.

    8 Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. E uropean Heart Journal 1991;12:315-21.

    9 Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. L ancet 1997;350:1349-53.

    10 Maisel AS, Krishaswamy P, Nowak RM, McOrd J, Hollander JE, Duc P et al. Rapid measurement of B-type natriuretic peptides in the emergency diagnosis of heart failer. NewE ngJ Med 2002; 347:161-7. 11Selvais PL, Donckier JE, Robert A, Laloux O, van L, Ahn S et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. E uropean Journal of Clinical Investigation 1998;28:636-42. 12 Yamamoto K, Burnett JCJ, Jougasaki M, Nishimura RA, Bailey KR, Saito Y et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.

  • Metrics
Share - Bookmark